Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein subunit gamma 5 pseudogene 3 (GNG5P3) is a pseudogene in humans, located on chromosome 11. It is designated as a pseudogene, meaning it does not encode a functional protein product and is not considered a functional target for therapeutic intervention or drug development[4]. Only the closely related gene GNG5, which encodes the G protein subunit gamma 5, is a protein-coding gene with recognized physiological roles[2][6]. GNG5P3 has no documented biological function, disease association, or known interacting drugs, as is typical for pseudogenes. If you are seeking a druggable G protein gamma subunit, refer instead to the protein-coding gene GNG5. Note: - GNG5P3 is not a drug target, it is a non-coding pseudogene. - There is nothing to suggest a biological or therapeutic role for GNG5P3[4]. - This entry may be incorrect if your intent was to refer to the functional protein-coding gene GNG5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein subunit gamma 5 pseudogene 3 (GNG5P3).